Lecozotan
From Self-sufficiency
Revision as of 21:09, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): nervous-system-drug-stub)
File:Lecozotan structure.svg | |
Systematic (IUPAC) name | |
---|---|
4-Cyano-N-[(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl]propyl]-N-2-pyridinylbenzamide hydrochloride | |
Identifiers | |
CAS Number | 434283-16-6 |
ATC code | none |
PubChem | CID 11156648 |
Chemical data | |
Formula | C28H30ClN5O3 |
Molar mass | 520.021 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Lecozotan is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients.[1] As of June 2008[update], the first Phase III clinical trial has been completed.[2]
Method of action
Lecozotan is a competitive, selective 5-HT1A receptor antagonist[3] which enhances the potassium-stimulated release of acetylcholine and glutamate.[4]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
- ↑ H. Spreitzer (August 13, 2008). "Neue Wirkstoffe - Lecozotan". Österreichische Apothekerzeitung (in German) (17/2007): 805.
- ↑ ClinicalTrials
- ↑ Schlechter, LE; Smith, DL; Rosenzweig-Lipson, S; Sukoff, SJ; Dawson, LA; Marquis, K; Jones, D; Piesla, M; Andree, T (June 10, 2005). "Lecotozan (SRA-333): A selective serotonin1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and promotes procognitive effects". Journal of Pharmacology and Experimental Therapeutics. 314 (3): 1274. doi:10.1124/jpet.105.086363. PMID 15951399.
- ↑ Childers, WE Jr, Harrison, BL, Abou-Gharbia, MA, Raje, S, Parks, V, Pangalos, MN, Schechter, LE (2007). "Lecozotan Hydrochloride". Drugs of the Future. 32 (5): 399–407. doi:10.1358/dof.2007.032.05.1092901.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Articles containing potentially dated statements from June 2008
- Articles with invalid date parameter in template
- All articles containing potentially dated statements
- 2Fix
- Antidementia agents
- Serotonin antagonists
- Piperazines
- Pyridines
- Nitriles
- Benzodioxins
- Acetamides
- Nervous system drug stubs
- CS1 maint: Unrecognized language
- CS1 maint: Multiple names: authors list